
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 17, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 17, 2024
Language: Английский
Clinical Rheumatology, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 7, 2025
Language: Английский
Citations
0Glycoconjugate Journal, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 11, 2025
Language: Английский
Citations
0Multidisciplinary Pain Journal, Journal Year: 2025, Volume and Issue: unknown, P. 2 - 10
Published: Jan. 1, 2025
Citations
0Medicine, Journal Year: 2025, Volume and Issue: 104(6), P. e41243 - e41243
Published: Feb. 7, 2025
Type 2 diabetes mellitus (T2DM) is an independent risk factor of knee osteoarthritis (KOA). This study was mainly based on data from the Taiwan National Health Insurance Database. Using big analysis, we showed that glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment helpful for patients with T2DM who have a lower KOA or total replacement (TKR). A 35,762 were included in this study. We divided these into 988 without and 372 received GLP-1RA those did not receive treatment. The matched sex, age, inclusion date by 1:1 propensity score, which control group. Cox proportional hazards analyses performed to compare TKR rate during maximum follow-up period 5 years. There 1976/744 without/with treatment, including 1052/322 men (53.24/43.28%) 924/422 women (46.76/56.72%). At end follow-up, there 46/39 (4.66/10.48%) underwent KOA/TKR than 87/70 (8.81/18.82%). hazard regression analysis among (adjusted ratio [HR] = .852; 95% confidence interval [CI] .784–.930, P < .001/ adjusted HR .913; CI .885–.977, .015, respectively). Kaplan–Meier cumulative patient with/without significantly different (log-rank test, .001, aimed provide clinicians option as reduce such patients.
Language: Английский
Citations
0Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: Feb. 28, 2025
Background Asperosaponin VI (AVI) is a naturally occurring monosaccharide derived from Dipsacus asperoides renowned for its anti-inflammatory and bone-protective properties. Objective To elucidate the specific mechanism through which AVI affects chondrocytes in osteoarthritis (OA). Methods For vitro experiments, primary were to molecular mechanisms underlying action of AVI.For vivo rat OA models established using modified Hulth method. The severity knee was evaluated 8 weeks post-surgery. Micro-CT imaging, hematoxylin-eosin staining, Safranin O-fast green staining used assess degeneration joints. Immunohistochemistry techniques conducted measure levels collagen II, MMP13, Nrf2, GPX4, ACSL4, HO-1 within cartilage tissues. ELISA assays performed those TNF-α, IL -6, PGE2 serum samples. Results alleviated chondrocyte apoptosis extracellular matrix degradation induced by IL-1β. It attenuated IL-6, while reducing Fe 2+ malondialdehyde (MDA). upregulated expression HO-1, GPX4 downregulating that ACSL4. Mechanistic studies revealed ML385-induced inhibition Nrf2 signaling pathway reversed increase ACSL4 increased MDA levels; treatment with erastin, ferroptosis inducer, produced comparable results. In experiments demonstrated improved bone volume/tissue volume trabecular separation values rats; Osteoarthritis Research Society International score; expression; downregulated MMP13 expression, decreased PGE2. Conclusion Our findings suggest promising therapeutic agent OA. exerted protective effect regulating Nrf2/GPX4/HO-1 axis inhibit cell improve osteoarthritis.
Language: Английский
Citations
0Frontiers in Cell and Developmental Biology, Journal Year: 2025, Volume and Issue: 13
Published: March 5, 2025
Osteoarthritis (OA) is a debilitating disease that predominantly impacts the hip, hand, and knee joints. Its pathology defined by progressive degradation of articular cartilage, formation bone spurs, synovial inflammation, resulting in pain, joint function limitations, substantial societal familial burdens. Current treatment strategies primarily target pain alleviation, yet improved interventions addressing underlying are scarce. Recently, exosomes have emerged as subject growing interest OA therapy. Numerous studies investigated to offer promising therapeutic approaches for through diverse vivo vitro models, elucidating mechanisms which from various cell sources modulate cartilage microenvironment promote repair. Preclinical investigations demonstrated regulatory effects originating human cells, including mesenchymal stem cells (MSC), fibroblasts, chondrocytes, macrophages, derived Chinese herbal medicines, on modulation repair signaling pathways. Additionally, encompass matrix, proliferation migration autophagy, apoptosis, mitigation oxidative stress. An increasing number exosome carrier scaffolds under development. Our review adopts multidimensional approach enhance comprehension pivotal functions exerted sourced types OA. Ultimately, our aim pinpoint targets capable regulating facilitating
Language: Английский
Citations
0Phytotherapy Research, Journal Year: 2025, Volume and Issue: unknown
Published: March 5, 2025
The complex nature of osteoarthritis (OA), driven by the intricate interplay genetic, environmental, and lifestyle factors, necessitates development a single treatment method, which is highly challenging. long-term use non-steroidal anti-inflammatory drugs (NSAIDs) corticosteroids often leads to adverse side effects like kidney damage stomach ulcers. Major health threats obesity aging create milieu chronic low-grade inflammation increased mechanical stress on joints resulting in cartilage deterioration. Additionally, postmenopausal women with lower circulating 17β-estradiol levels experience accelerated joint deterioration due immune activity production pro-inflammatory cytokines, elevated MMP expression decreased type II collagen synthesis. Polyphenols are nature's gifted magic molecules, possess diverse biological properties anti-oxidant, anti-bacterial, anti-inflammatory, estrogenic, insulin-sensitizing effects, can manage treat all multi-factorial contributing factors OA effectively. Certain polyphenols act as phytoestrogens mimic natural estrogen binding ERα ERβ SERMs prevent degradation articular thereby alleviating osteoarthritic conditions. These molecules downregulate various apoptotic genes, matrix-degrading proteases (MMPs) while upregulating major ECM proteins collagen, aggrecan, proteoglycans animal models. This review provides comprehensive overview molecular mechanisms involved also explores therapeutic potential different mitigating their protective effect inhibiting extracellular matrix (ECM) enhancing homeostasis.
Language: Английский
Citations
0Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: March 19, 2025
Background Osteoarthritis (OA) and impaired glucose tolerance (IGT) frequently coexist, leading to compounded clinical metabolic challenges. This study investigates the effects of metformin in improving both outcomes (pain, stiffness, physical function) parameters (inflammatory markers, lipid profile, BMI) patients with knee OA IGT. Methods The included 60 diagnosed Participants were divided into two groups: 26 received standard treatment without (Without Metf), while 34 (500 mg twice daily) for 3 months, addition (With Metf). Clinical assessments (WOMAC, Lequesne Algofunctional Index, KOOS, VAS) markers (CRP, NLR, SOD, measured before treatment, after 1 month, months. Results With Metf group showed significantly greater improvements pain, function, quality life compared Without group. Metformin also led significant reductions inflammatory profiles health indicators. demonstrated enhanced BMI, waist-to-hip ratio, waist-to-height ratio. Furthermore, need increased NSAID doses was predicted by factors such as pain severity markers. Conclusion effectively alleviates osteoarthritis symptoms improves Further research is needed explore its long-term on joint health, potential role management
Language: Английский
Citations
0Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)
Published: Aug. 27, 2024
Osteoarthritis (OA) is a common joint disease associated with the aging of population, and it reduces quality life patients. It characterized by destruction articular cartilage secretion inflammatory cytokines. Owing to unclear pathogenesis OA, current treatment methods have significant limitations. Oxidative stress has been revealed play an important role in development OA. Our experiments indicated that levels GSH decreased level MDA increased chondrocytes, which induced ferroptosis chondrocytes We also was main mechanism caused addition activator erastin inhibitor ferrostatin-1. NOX1 modulator oxidative increasing generation reactive species (ROS). suppressed expression through cell transfection. The collagen II MMP13, IL-1β TNF-α were reversed. An increase mitochondrial membrane potential decrease intracellular ROS indicate improvement damage. Additionally, we determined effect Nrf2/HO-1 pathway on NOX1-mediated chondrocyte injury. found inhibited Nrf2/HO-1, but activation Nrf2 improved damage vivo vitro. This study induces inhibiting pathway. findings contribute revealing providing targets for drug design optimizing clinical
Language: Английский
Citations
3Gels, Journal Year: 2024, Volume and Issue: 10(7), P. 451 - 451
Published: July 10, 2024
An electrochemical sensor sensitive to coenzyme A (CoA) was designed using a CoA-responsive polyallylamine-manganese oxide-polymer dot nanogel coated on the electrode surface detect various genetic models of osteoarthritis (OA). The responded abundance CoA in OA, causing breakage MnO
Language: Английский
Citations
2